Drugs Made In America Acquisition II Corp.
DMIIR- 交易所
- Nasdaq
- 產業
- Blank Checks
- SEC CIK
- 0002040475
內部人交易
每一列是一份 Form 4 申報裡同一種交易的合計。預設只顯示公開市場買進（P）與賣出（S）；要看公司授予、行使選擇權等其他代碼，請調整篩選條件。
| 申報時間（美東） | 交易日 | 內部人 | 交易 | 股數 | 均價 | 金額 | 交易後持股 | 持股變化 | 申報 |
|---|---|---|---|---|---|---|---|---|---|
| 2025/10/1 | 2025/9/26 | Stockwell LynnCEO and Exe. Chair of Board | P買進Ordinary shares | +70 萬 | – | – | 1,507.5 萬 | +4.9% | SEC |
| 2025/10/1 | 2025/9/26 | Stockwell LynnCEO and Exe. Chair of Board | S賣出Ordinary shares | −796.67 萬 | – | – | 670.83 萬 | −54.3% | SEC |
| 2025/10/1 | 2025/9/26 | Stockwell LynnCEO and Exe. Chair of Board | P買進Ordinary shares · 衍生 | +7 萬 | – | – | 70 萬 | – | SEC |
| 2025/10/1 | 2025/9/26 | Drugs Made In America Acquisition II LLC持股 10% 以上大股東 | P買進Ordinary shares | +70 萬 | – | – | 1,507.5 萬 | +4.9% | SEC |
| 2025/10/1 | 2025/9/26 | Drugs Made In America Acquisition II LLC持股 10% 以上大股東 | S賣出Ordinary shares | −796.67 萬 | – | – | 670.83 萬 | −54.3% | SEC |
| 2025/10/1 | 2025/9/26 | Drugs Made In America Acquisition II LLC持股 10% 以上大股東 | P買進Ordinary shares · 衍生 | +70 萬 | – | – | 70 萬 | – | SEC |